Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 | ||
By: GlobeNewswire - 04 Mar 2024 | Back to overview list |
|
Montrouge, France, March 4, 2024 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatments for food allergies, today announced the Company will host a conference call and live audio webcast on Thursday, March 7th, at 5:00 p.m. ET to review full year 2023 financial results and provide a business update. Interested participants may access this call via the below teleconferencing numbers and reference the DBV Technologies call: United States: 1-844-481-2866 A live webcast of the call will also be available under "Events" in the Investors section of the Company’s website: https://dbv-technologies.com/investor-overview/events. A replay of the presentation will also be available on DBV’s website after the event. About DBV Technologies Investor Contact Media Contact aurora.krause-ext@dbv-technologies.com Viaskin and EPIT are trademarks of DBV Technologies. Attachment |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |